Interventions to increase HPV vaccination coverage: A systematic review

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 6, 2016, Pages 1566-1588

  Smulian, Elizabeth A ^a,b   Mitchell, Krista R ^c   Stokley, Shannon ^b  

^a Association of Schools and Programs of Public Health   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Carter Consulting Inc   (United States)

Author keywords

coverage; HPV; human papillomavirus; interventions; vaccination

Indexed keywords

HUMAN; QUANTITATIVE STUDY; SYSTEMATIC REVIEW; UNITED STATES; VACCINATION; WART VIRUS; BEHAVIOR THERAPY; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTILIZATION;

WART VIRUS VACCINE;

BEHAVIOR THERAPY; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; VACCINATION;

EID: 84976329735     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1125055     Document Type: Review

References (62)

1. C.L.Satterwhite, E.Torrone, E.Meites, E.F.Dunne, R.Mahajan, M.C.Ocfemia, J.Su, F.Xu, H.Winstock. Sexually transmitted infections among US women and men: prevalence and incidence estimates 2008. Sex Transm Dis 2013; 40(3):187-93; PMID:23403598
2. M.Saraiya, E.R.Unger, T.D.Thompson, C.F.Lynch, B.Y.Hernandez, C.W.Lyu, M.Steinau, M.Watson, E.J.Wilkinson, C.Hopenhayn, et al. US assessment of HPV types in cancer: implications for current and 9-valent HPV vaccines. J Natl Cancer I 2015; 107(6):djv086
3. L.E.Markowitz, E.F.Dunne, M.Saraiya, H.Chesson, C.R.Curtis, J.Gee, J.A.Bocchini, E.R.Unger. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) 2014; 63(RR05):1-30
4. L.E.Markowitz, E.F.Dunne, M.Saraiya, H.W.Lawson, H.Chesson, E.R.Unger. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2007; 56(RR02):1-24
5. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2010; 59(20):626-9
6. E.Petrosky, J.A.Bocchini, S.Hariri, H.Chesson, C.R.Curtis, M.Saraiya, E.R.Unger, L.E.Markowitz. Use of 9-Valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2015; 64(11):300-4
7. C.J.N.Lacey, C.M.Lowndes, K.V.Shah. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/34-41
8. J.T.Schiller, X.Castellsague, S.M.Garland. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30(Suppl 5):F123-38; PMID:23199956
9. L.E.Markowitz, S.Hariri, C.Lin, E.F.Dunne, M.Steinau, G.McQuillan, E.R.Unger. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013; 208:385-93; PMID:23785124
10. A.Leval, E.Herweijer, L.Arnheim-Dahlstrom, H.Walum, E.Frans, P.Sparén, J.F.Simard. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012; 206(6):860-6; PMID:22815381
11. T.R.Read, J.S.Hocking, M.Y.Chen, B.Donovan, C.S.Bradshaw, C.K.Fairley. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87:544-7; PMID:21970896
12. J.M.Brotherton, M.Fridman, C.L.May, G.Chappell, A.M.Saville, D.M.Gertig. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377(9783):2085-92; PMID:21684381
13. S.E.Powell, S.Hariri, M.Steinau, H.M.Bauer, N.M.Bennett, K.C.Bloch, L.M.Niccolai, S.Schaffer, E.R.Unger, L.E.Markowitz. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine 2012; 31(1):109-13; PMID:23137842
14. S.Reagan-Steiner, D.Yankey, J.Jeyarajah, L.D.Elam-Evans-, J.A.Singleton, C.R.Curtis, J.MacNeil, L.E.Markowitz, S.Stokley. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years: United States, 2014. Morbidity and Mortality Weekly Report (MMWR). 2015; 64(29):784-92
15. Healthy People 2020 objectives: immunization and infectious diseases. Available at https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed May30, 2015
16. President's Cancer Panel. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President's Cancer Panel. Bethesda, MD: National Cancer Institute. 2014. Available at http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm. Accessed May30, 2015
17. L.Fu, L.Bonhomme, S.Cooper, J.Joseph, G.Zimet. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine 2014; 32:1901-20; PMID:24530401
18. N.Brewer, K.Fazekas. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649
19. H.Gamble, J.Klosky, G.Parra, M.Randolph. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psych 2010; 35(7):704-15; http://dx.doi.org/10.1093/jpepsy/jsp108
20. D.Holman, V.Bernard, K.Roland, M.Watson, N.Liddon, S.Stokley. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168(1):76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752
21. T.Walhart. Parents, adolescents, children and the human papillomavirus vaccine: a review. Int Nurs Rev 2012; 59:305-11; PMID:22897180; http://dx.doi.org/10.1111/j.1466-7657.2012.00991.x
22. L.Niccolai, C.Hansen. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr 2015; 169(7):686-92; PMID:26010507; http://dx.doi.org/10.1001/jamapediatrics.2015.0310
23. Community Preventive Services Task Force. The guide to community preventive services: increasing appropriate vaccination. Available at |www.thecommunityguide.org/vaccines/index.html. Last updated: February 13, 2015. Accessed May30, 2015
24. Community Preventive Services Task Force. What is the Community Guide? Available at www.thecommunityguide.org/about/index.html. Last updated: April 6, 2015. Accessed October26, 2015
25. E.Bugenske, S.Stokley, A.Kennedy, C.Dorell. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics 2012; 129:1056-63; PMID:22566425; http://dx.doi.org/10.1542/peds.2011-2641
26. A.Dempsey, S.Schaffer. Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Prev Med 2011; 52(3–4):268-9; PMID:21195727
27. R.Potter, S.DeVita, P.Vranesich, M.Boulton. Adolescent immunization coverage and implementation of new school requirements in Michigan, 2010. Am J Public Health 2014; 104(8):1526-33; PMID:24922144; http://dx.doi.org/10.2105/AJPH.2014.301910
28. C.Chao, M.Preciado, J.Slezak, L.Xu. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolescent Health 2015; 56:85-90; http://dx.doi.org/10.1016/j.jadohealth.2014.08.014
29. E.Kharbanda, M.Stockwell, H.Fox, R.Andres, M.Lara, V.Rickert. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29:2537-41; PMID:21300094; http://dx.doi.org/10.1016/j.vaccine.2011.01.065
30. A.Patel, L.Stern, Z.Unger, E.Debevec, A.Roston, R.Hanover, J.Morfesis. Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine 2014; 32: 2428-33; PMID:24631099; http://dx.doi.org/10.1016/j.vaccine.2014.02.095
31. C.A.Suh, A.Saville, M.F.Daley, J.E.Glazner, J.Barrow, S.Stokley, F.Dong, B.Beaty, L.M.Dickinson, A.Kempe. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012; 129(6):1437-45; http://dx.doi.org/10.1542/peds.2011-1714
32. P.G.Szilagyi, C.Albertin, S.G.Humiston, C.M.Rand, S.Schaffer, H.Brill, J.Stankaitis, B.K.Yoo,, A.K.Blumkin, S.Stokley. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr 2013; 13(3):204-13; PMID:23510607; http://dx.doi.org/10.1016/j.acap.2013.01.002
33. D.Bar-Shain, M.Stager, A.Runkle, J.Leon, D.Kaelber. Direct messaging to parents/guardians to improve adolescent immunizations. J Adolescent Health 2015; 56:S21-26; http://dx.doi.org/10.1016/j.jadohealth.2014.11.023
34. J.Morris, W.Wang, L.Wang, K.M.Peddecord, M.Sawyer. Comparison of reminder methods in selected adolescents with records in an immunization registry. J Adolescent Health 2015; 56:S27-32; http://dx.doi.org/10.1016/j.jadohealth.2015.01.010
35. C.M.Rand, H.Brill, C.Albertin, S.G.Humiston, S.Schaffer, L.P.Shone, A.K.Blumkin, P.G.Szilagyi. Effectiveness of centralized text message reminders on human papillomavirus coverage for publicly insured adolescents. J Adolescent Health 2015; 56:S17-20; http://dx.doi.org/10.1016/j.jadohealth.2014.10.273
36. S.Hopfer. Effects of a narrative HPV vaccine intervention aimed at reaching college women: a randomized controlled trial. Prev Sci 2012; 13:173-82; PMID:21993613; http://dx.doi.org/10.1007/s11121-011-0254-1
37. R.C.Vanderpool, E.L.Cohen, R.A.Crosby, M.G.Jones, W.Bates,, B.R.Casey, T.Collins. “1-2-3 Pap” intervention improves HPV vaccine series completion among Appalachian women. J Commun 2013; 63:95-115; PMID:26560123; http://dx.doi.org/10.1111/jcom.12001
38. A.Kempe, J.Barrow, S.Stokley, A.Saville, J.E.Glazner, C.Suh, S.Federico, L.Abrams, L.Seewald, B.Beaty, et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics 2012; 129:1446-52; http://dx.doi.org/10.1542/peds.2011-2921
39. D.Patel, M.Zochowski, S.Peterman, A.Dempsey, S.Ernst, V.Dalton. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health 2012; 60(2):151-61; PMID:22316412; http://dx.doi.org/10.1080/07448481.2011.580028
40. J.Cates, A.Shafer, S.Diehl, A.Deal. Evaluating a county-sponsored social marketing campaign to increase mothers' initiation of HPV vaccine for their pre-teen daughters in a primary rural area. Soc Mar Q 2011; 17(1):4-26; PMID:21804767; http://dx.doi.org/10.1080/15245004.2010.546943
41. J.Cates, S.Diehl, J.Crandell, T.Coyne-Beasley. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine 2014; 32:4171-8; PMID:24886960; http://dx.doi.org/10.1016/j.vaccine.2014.05.044
42. P.G.Szilagyi, S.G.Humiston, S.Gallivan, C.Albertin, M.Sandler, A.K.Blumkin. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adol Med 2011; 165(6):547-53; http://dx.doi.org/10.1001/archpediatrics.2011.73
43. V.Rickert, B.Auslander, D.Cox, S.Rosenthal, R.Rupp, G.Zimet. School-based HPV immunization of young adolescents: effects of two brief health interventions. Hum Vaccin Immunother 2015; 11(2):315-21; PMID:25692717; http://dx.doi.org/10.1080/21645515.2014.1004022
44. M.T.Ruffin, M.A.Plegue, P.G.Rockwell, A.P.Young, D.A.Patel, M.W.Yeazel. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med 2015; 28(3):324-33; PMID:25957365; http://dx.doi.org/10.3122/jabfm.2015.03.140082
45. P.G.Szilagyi, J.R.Serwint, S.G.Humiston, C.M.Rand, S.Schaffer, P.Vincelli, N.Dhepyasuwan, A.Blumkin, C.Albertin, C.R.Curtis. Effect of provider prompts on adolescent immunization rates: a randomized trial. Acad Pediatr 2015; 15:149-57; PMID:25748976; http://dx.doi.org/10.1016/j.acap.2014.10.006
46. M.B.Gilkey, A.M.Dayton, J.L.Moss, A.C.Sparks, A.H.Grimshaw, J.M.Bowling, N.T.Brewer. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics 2014; 134:346-53; http://dx.doi.org/10.1542/peds.2013-4257
47. B.Cassidy, B.Braxter, D.Charron-Prochownik, E.Schlenk. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care 2014; 28(2):155-64; PMID:23522561; http://dx.doi.org/10.1016/j.pedhc.2013.01.002
48. A.G.Fiks, R.W.Grundmeier, S.Mayne, L.Song, K.Feemster, D.Karavite, C.C.Hughes, J.Massey, R.Keren, L.M.Bell, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics 2013; 131:1114-24; PMID:23650297; http://dx.doi.org/10.1542/peds.2012-3122
49. E.C.Matheson, A.Derouin, M.Gagliano, J.A.Thompson, J.Blood-Siegfried. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care 2014; 28(4):35-9; PMID:23195652; http://dx.doi.org/10.1016/j.pedhc.2013.09.001
50. J.M.Moss, P.Reiter, A.Dayton,, N.T.Brewer. Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers. Vaccine 2012; 30:4960-3; PMID:22652406; http://dx.doi.org/10.1016/j.vaccine.2012.05.042
51. R.Perkins, L.Zisblatt, A.Legler, E.Trucks, A.Hanchate, S.Sheinfeld Gorin. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine 2015; 33:1223-9; PMID:25448095; http://dx.doi.org/10.1016/j.vaccine.2014.11.021
52. B.Pahud, S.Clard, J.C.Herigon, A.Sherman, D.A.Lynch, A.Hoffman, M.A.Jackson. A pilot program to improve vaccination status for hospitalized children. Hosp Pediatr 2015; 5(1):35-41; PMID:25554757; http://dx.doi.org/10.1542/hpeds.2014-0027
53. R.Chung, E.Walter, A.Kemper, A.Dayton. Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina. J Adolescent Health 2015; 56:S14-16; http://dx.doi.org/10.1016/j.jadohealth.2014.10.272
54. S.Staras, S.Vadaparampil, M.Livingston, L.Thompson, A.Sanders, E.Shenkmen. Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents. J Adolescent Health 2015; 56:S40-46; http://dx.doi.org/10.1016/j.jadohealth.2014.11.024
55. D.G.Bundy, N.M.Persing, B.S.Solomon, T.M.King, P.Murakami, R.E.Thompson, L.D.Engineer, C.U.Lehmann, M.R.Miller. The ImmProve Project: Leveraging electronic health record data to promote immunization delivery. Acad Pediatr 2013; 13(5):458-65; PMID:23726754http://dx.doi.org/10.1016/j.acap.2013.03.004
56. M.F.Daley, A.Kempe, J.Pyrzanowski, T.M.Vogt, L.M.Dickinson, D.Kile, H.Fang, D.J.Rinehart, J.C.Shlay. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolescent Health 2014; 54:282-8; http://dx.doi.org/10.1016/j.jadohealth.2013.12.011
57. B.Stubbs, C.Panozzo, J.Moss, P.Reiter, D.Whitesell, N.Brewer. Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav 2014; 38(1):92-102; PMID:24034684; http://dx.doi.org/10.5993/AJHB.38.1.10
58. D.M.Harper, I.Verdenius, G.D.Harris, A.L.Barnett, B.E.Rosemergey, A.M.Arey, J.Wall, G.J.Malnar. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series. Prev Med 2014; 61:20-5; PMID:24440159; http://dx.doi.org/10.1016/j.ypmed.2014.01.007
59. H.Chesson, D.Ekwueme, M.Saraiya, M.Watson, D.Lowy, L.E.Markowitz. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012; 30(42):6016-9; PMID:22867718; http://dx.doi.org/10.1016/j.vaccine.2012.07.056
60. S.Rosenthal, T.Weiss, G.Zimet, L.Ma, M.Good, M.Vichnin. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 2011; 29(5):890-895; PMID:20056186; http://dx.doi.org/10.1016/j.vaccine.2009.12.063
61. A.Hofstetter, S.Rosenthal. Health care professional communication about STI vaccines with adolescents and parents. Vaccine 2014; 32(14):1616-23; PMID:23791695; http://dx.doi.org/10.1016/j.vaccine.2013.06.035
62. A.Hofstetter, S.Rosenthal. Factors impacting HPV vaccination: lessons for health care professionals. Exp Rev Vaccines 2014; 13(8):1013-26; http://dx.doi.org/10.1586/14760584.2014.933076